Charles Sternberg, Assistant Editor02.10.21
Brian P. Kemp, governor of Georgia, has rolled out House Bill 304, the Georgia Made Medical Manufacturing Act, carried by representative Jodi Lott (R - Evans).
One of the Kemp Administration's key initiatives for the 2021 Legislative Session, this bill will incentivize the production of medicines and medical devices in Georgia, limiting the state's need to compete with other states or foreign nations for critical supplies.
Bringing Much Needed Supplies to Georgia
"One of the lessons we learned early on in the pandemic is that we cannot waste time in bidding wars with others for life-saving supplies," said Kemp. "Last session, we incentivized the production of PPE in the Peach State to alleviate that problem, build up our stockpile, and make it easier to stay in business in the era of COVID-19. HB 304 is a natural next step to that program and will help us build on Georgia's momentum to become a leader in all sectors of the health care industry. No one state or nation should hold a monopoly on critical medicines and medical supplies, and we should bring these industries and the jobs that come with them back to America and here to Georgia."
During the 2019-2020 Legislative Session, the State of Georgia enacted a PPE Tax Credit to incentivize manufacturers of personal protective equipment, including those existing Georgia manufacturers which did not traditionally manufacture PPE but began doing so in response to COVID-19. The Georgia Made Medical Manufacturing Act is modeled off that legislation, increasing the amount of credit available under the Jobs Tax Credit to incentivize job creation and investment in the medical equipment and pharmaceutical manufacturing industries.
This measure will work to ensure collaboration between the public and private sector in Georgia to cultivate long-term growth and development of the state's health care ecosystem. Currently, the Georgia Department of Economic Development's COVID-19 Suppliers Map features more than 350 suppliers of PPE throughout the state.
One of the Kemp Administration's key initiatives for the 2021 Legislative Session, this bill will incentivize the production of medicines and medical devices in Georgia, limiting the state's need to compete with other states or foreign nations for critical supplies.
Bringing Much Needed Supplies to Georgia
"One of the lessons we learned early on in the pandemic is that we cannot waste time in bidding wars with others for life-saving supplies," said Kemp. "Last session, we incentivized the production of PPE in the Peach State to alleviate that problem, build up our stockpile, and make it easier to stay in business in the era of COVID-19. HB 304 is a natural next step to that program and will help us build on Georgia's momentum to become a leader in all sectors of the health care industry. No one state or nation should hold a monopoly on critical medicines and medical supplies, and we should bring these industries and the jobs that come with them back to America and here to Georgia."
During the 2019-2020 Legislative Session, the State of Georgia enacted a PPE Tax Credit to incentivize manufacturers of personal protective equipment, including those existing Georgia manufacturers which did not traditionally manufacture PPE but began doing so in response to COVID-19. The Georgia Made Medical Manufacturing Act is modeled off that legislation, increasing the amount of credit available under the Jobs Tax Credit to incentivize job creation and investment in the medical equipment and pharmaceutical manufacturing industries.
This measure will work to ensure collaboration between the public and private sector in Georgia to cultivate long-term growth and development of the state's health care ecosystem. Currently, the Georgia Department of Economic Development's COVID-19 Suppliers Map features more than 350 suppliers of PPE throughout the state.
